Fossati G, Cooke A, Papafio R Q, Haskins K, Stockinger B
Division of Molecular Immunology, The National Institute for Medical Research, London NW7 1AA, United Kingdom.
J Exp Med. 1999 Aug 16;190(4):577-83. doi: 10.1084/jem.190.4.577.
In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.
在本文中,我们检验了一个假说,即表达于致糖尿病性T细胞上的第二个T细胞受体(TCR)的激活可能引发糖尿病的发病。构建了两个TCR转基因品系的杂交组合,即携带致糖尿病性TCR的BDC2.5品系和携带针对C5的特异性受体的A18品系,以监测通过C5 TCR激活后糖尿病的发展情况。F1 BDC2.5×A18小鼠在3至4月龄后自发发生糖尿病。尽管它们的T细胞组成性地表达两种TCR,但A18受体的表达水平极低。体外激活双TCR T细胞,然后将其过继转移至新生或成年F1小鼠体内,导致转移后10天内糖尿病发病和死亡。相比之下,用不同形式的C5抗原对F1小鼠进行体内免疫,不仅未能诱导糖尿病,反而保护小鼠免于自发发生糖尿病。我们提出,对低水平TCR细胞的抗原刺激产生的信号不足以实现完全激活,反而导致无反应性。